The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Hilton Hotel, Buenos Aires, Argentina, March 11-14, 2010
Thursday, March 11, 2010
Hall C, Hilton Hotel Challenges in the Treatment of Type 2 Diabetes: Implications for Glycemic Control Program Overview New research is continuing to improve our knowledge and understanding of the pathophysiology of type 2 diabetes mellitus (T2DM), as well as providing possibilities for new treatment options. These new therapeutic agents may provide additional benefits to address the common challenges of diabetes treatment. Recent clinical trial data have also given cause for reassessing the current treatment paradigm, particularly with respect to the intensity of glycemic control. In this Lilly Diabetes satellite symposium, participants will examine the importance of beta-cell function in T2DM and explore the role and mechanisms of incretin-based therapies in the management of this disease. They will also review data from clinical trials to assess whether intensive glycemic control is advantageous at all stages of disease in all patient groups. In addition to attending presentations that explore these topics, participants will have the opportunity to interact with international thought leaders and peers from the region during scheduled panel Q&A sessions. Agenda Program Chair: León Litwak, Argentina 11:00 – 11:20 Refreshments 11:20 – 11:30 Opening Remarks León Litwak, Argentina 11:30 – 12:00 The Pathophysiology of T2DM: The Central Role of the Beta Cell Stefano Del Prato, Italy 12:00 – 12:30 Incretin Actions and Current Incretin-based Therapies Michaela Diamant, The Netherlands 12:30 – 13:00 Q&A Session 13:00 – 13:45 Lunch 13:45 – 14:15 The Clinical Benefits of Intensive Glycemic Control are Restricted to Early Intervention Juan José Gagliardino, Argentina 14:15 – 14:45 Intense Glycemic Control is Not Advised in Patients with Longstanding Hyperglycemia and a History of Cardiovascular Disease Guntram Schernthaner, Austria 14:45 – 15:20 Panel Discussion 15:20 – 15:30 Closing Remarks León Litwak, Argentina